Search

Objective: To evaluate patients who underwent acute and chronic peritoneal dialysis (PD) under the age of one one in terms of etiology, complications, and prognosis over 20 years and to compare the results between the first and last 10 years of acute and chronic peritoneal dialysis. Material and Method: Seventy-four peritoneal dialysis patients under the age of one in the Division of Pediatric Nephrology and Neonatal Intensive Care Unit of our hospital between January 2002 and December 2023 were evaluated retrospectively. The patients were divided into two groups: patients admitted in the 2002-2013 period (Group I) and patients admitted in the 2013-2023 period (Group II). Patients in Group I and Group II were compared in terms of acute and chronic peritoneal dialysis etiology, complications, and prognosis. Result: Forty-four of the patients (60%) were newborns, and the remaining 30 were infants (40%). There were 39 patients in Group I and 35 patients in Group II. There was no difference between Group I and Group II for acute dialysis in terms of neonatal and infant diagnoses, infectious and non-infectious complications, and prognosis (p>0.05). There was no difference between Group I and Group II in terms of neonatal and infant diagnoses, infectious and non-infectious complications, and infant prognosis (p>0.05). There was no death in the newborns in Group II and patient survival was higher than in the newborns in Group I (p=0.019). Conclusion: Peritoneal dialysis is the most commonly used method for renal replacement therapy in children facing both acute and chronic renal failure. In the last decade, despite high-quality care in the neonatal care unit, positive technological developments and effective management of PD, the most common infectious complication was still peritonitis, and the non-infectious complication was dialysate leakage, as in the previous 10 years. [ABSTRACT FROM AUTHOR]

Copyright of Turkiye Klinikleri Journal of Nursing Sciences is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Nursing Effect / Etkili Hemşirelik Dergisi is the property of Dokuz Eylul Universitesi Hemsirelik Fakultesi Elektronik Dergisi and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Aim: This study was conducted as a correlational and comparative pilot study to determine the relationship between emotional reactivity and death anxiety in dialysis patients. Method: The study was conducted with a total of 140 people, including 70 hemodialysis (HD) and 70 peritoneal dialysis (PD) patients. A questionnaire form, Turkish Death Anxiety Scale (TDAS) and Emotion Reactivity Scale (ERS) were used for data collection. Results: There was no difference between the mean ERS and TDAS scores of hemodialysis and peritoneal dialysis patients. A moderate positive correlation was found between the mean ERS and TDAS scores in HD and PD groups (p

Objective: The aim of this study was to determine the level of fear, anxiety, and obsession caused by the coronavirus disease-2019 (COVID-19) pandemic in hemodialysis (HD) and peritoneal dialysis (PD) patients, and to make a comparison with healthy individuals. Methods: This analytical cross-sectional study was conducted with 162 people (n=162) who were HD or PD patients or healthy individuals when lockdown measures were in force. Data were collected using a personal information form, the coronavirus anxiety scale (CAS), the obsession with COVID-19 scale (OCS), and the fear of COVID-19 scale. Results: The fear and OCS scores of the PD patients were significantly higher than those of the HD patients and healthy individuals (p<0.01). There was no difference between the groups with regard to the CAS scores. Positive correlations were found in the study between the COVID-19 Fear scale and the CAS and OCS (r=0.353; r=0.564 respectively; p<0.01). A positive correlation was also found between the COVID-19 anxiety scale and OCS (r=0.331; p<0.01). Conclusion: The fear, anxiety, and obsession levels of HD patients were similar to those of healthy individuals, but higher in PD patients. It is recommended that doctors and nurses should provide and maintain social and psychological support in extraordinary situations such as the pandemic, especially to patients with chronic illnesses such as PD patients who have to perform their own treatment at home, in order to reduce levels of fear, anxiety, and obsession. [ABSTRACT FROM AUTHOR]

Aim: This study was conducted as a correlational and comparative pilot study to determine the relationship between emotional reactivity and death anxiety in dialysis patients. Material and Method: The study was conducted with a total of 140 people, including 70 hemodialysis and 70 peritoneal dialysis patients. A questionnaire form, Turkish Death Anxiety Scale and Emotion Reactivity Scale were used for data collection. Results: There was no difference between the mean Emotion Reactivity Scale and Turkish Death Anxiety Scale scores of hemodialysis and peritoneal dialysis patients. A moderate positive correlation was found between the mean Emotion Reactivity Scale and Turkish Death Anxiety Scale scores in hemodialysis and peritoneal dialysis groups (p<0.05). It was determined that 15.3% of Turkish Death Anxiety Scale scores of hemodialysis patients and 26.2% of Turkish Death Anxiety Scale scores of peritoneal dialysis patients were explained by Emotion Reactivity Scale. Conclusion: It was observed that death anxiety and emotional reactivity were at a moderate level in hemodialysis and peritoneal dialysis patients and there was a similarity between dialysis modalities. [ABSTRACT FROM AUTHOR]

Although hemoperitoneum is a benign and common complication of chronic peritoneal dialysis the apperance of the effluent will be devastating for the patients. In women of reproductive age group gynecological causes are the common etiological factors. A 17 years old girl who had been on automated peritoneal dialysis for six months was admitted because of bloody effluent lasting for two days. At admission she described mild abdominal pain; physical examination was unremarkable and bleeding time and coagulation profile was normal. Abdominal ultrasound revealed hemorrhagic cysts on left ovary. Peritoneal effluent was cleared by using rapid exchanges with room temperature dialysate. Hemoperitoneum is a well recognized complication of peritoneal dialysis in women of reproductive age.Abdominal ultrasound is the first, easily applicable and reliable diagnostic modality in order to detect underlying causes of hemoperitoneum. Performing rapid exchanges with cold-room temperature dialysate is the mainstay of treatment. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Uludag University Medical Faculty / Uludağ Üniversitesi Tıp Fakültesi Dergisi is the property of Journal of Uludag University Medical Faculty and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Aim: Hemodialysis and peritoneal dialysis are renal replacement treatment options in patients with chronic renal failure. Mortality and morbidity rates are higher in hemodialysis and peritoneal dialysis patients when compared to the healthy population. Comorbidities of the patients play roles in the high mortality and morbidity rates. In the present study, the comorbidities of hemodialysis and peritoneal dialysis patients were evaluated; and the Charlson Comorbidity Index, whose reliability was proven in many studies before, was compared and discussed. Materials and Method: A total of 154 patients (78 hemodialysis and 76 peritoneal dialysis patients), who were followed up for end-stage renal disease, were included in the study. The Charlson Comorbidity Index scores of the patients were calculated. The Charlson Comorbidity Index score and parameters were compared between patient groups on hemodialysis and peritoneal dialysis. Results: The Charlson Comorbidity Index was found to be significantly higher in peritoneal dialysis patients than in hemodialysis patients (p=0.001). It was also found that the frequency of congestive heart failure, cerebrovascular accident, and connective tissue, which are the parameters of the Charlson Comorbidity Index, were significantly different between the groups (p

ABSTRACT Background: Severe acute problems, which are related to different systems, could be reasons for applying to the emergency department in patients with peritoneal dialysis. In this study, the aim was to evaluate the reasons and treatment of applications to the emergency department in these patients after office hours. Methods: This study included followed up CAPD patients, who applied to the Emergency Department between January 2017 and May 2020 at our University. Demographical, biochemical, and clinical data, such as, renal, peritoneal, and weekly Kt/V, normalized protein catabolic rate (nPCR), peritoneal UF, and GFR were recorded from the outpatient’s department data. In addition, reasons for application to emergency services and hospitalization were evaluated. Results: 38 peritoneal dialysis patients applied 88 times to the emergency department and were hospitalized between 2017 and 2020. Patients, who applied after office hours were included in the study. Around 130 patients were regularly followed-up in our CAPD outpatient clinic during this period. While the most important peritoneal reasons for admission were exit site infection and catheter dysfunction, extra peritoneal complications were various. Patients were hospitalized in the Cardiology and General Surgery departments with a high rate of acute cardiovascular events and acute abdominal pathologies. Conclusion: Although the first approach to these patients in the emergency department is usually performed by a consulted nephrologist, effective and priority treatment could only be given by an emergency doctor, who has knowledge about the special problems of dialysis patients.

Copyright of Turkiye Klinikleri Journal of Internal Medicine / Türkiye Klinikleri İç Hastalıkları Dergisi is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Ege Journal of Medicine is the property of Ege University, Faculty of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Namık Kemal Tıp Dergisi is the property of Galenos Yayinevi Tic. LTD. STI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Osmangazi Journal of Medicine / Osmangazi Tip Dergisi is the property of Eskisehir Osmangazi University and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: Mucocutaneous lesions, secondarily to primary diseases or dialysis treatment, are quite often observed in patients with end-stage renal failure. This study aims to detect the prevalence of dermatological manifestations in patients with end-stage renal failure that receive hemodialysis and peritoneal dialysis and compare the differences between the 2 groups. Methods: A total of 67 patients, 49 receiving hemodialysis (HD) and 18 receiving peritoneal dialysis (PD), were included in the study. The age range was between 20-90. The patients' medical anamneses were recorded and detailed skin, hair, nail, and mucosa examinations were performed under proper lighting and the findings were recorded. When necessary, microbiological and histopathological additional examinations from the lesions were performed. Results: Xerosis was the most frequently observed skin finding in the 2 groups that received HD and PD. Ecchymosis was detected significantly higher in the HD group than the PD group. As a mucous finding, coated tongue in the HD group and xerostomia in the PD group were observed. The most frequent nail finding in both groups was half and half nails. Splinter hemorrhage was found to be significantly higher in the HD group than in the PD group. In the hemodialysis group, the hair finding lower extremity hair loss rate was significantly higher than the peritoneal dialysis group. Hair loss on the scalp was the most frequent in the PD receiving group. Conclusion: All of the patients included in the study had at least one dermatological finding. Minor differences in terms of mucocutaneous findings were detected in the 2 groups that received HD and PD. [ABSTRACT FROM AUTHOR]

Objective: Peritonitis is a major complication of peritoneal dialysis (PD) and leads to significant mortality and technical failure. Understanding local peritonitis rates and microbiologic profiles are important for the prevention and appropriate management of PD-related peritonitis. We investigated the incidence rate, causative agents, and outcomes of PD-related peritonitis episodes. Methods: This retrospective study enrolled all patients who were receiving PD and have been treated for PD-related peritonitis between February 2005 and November 2021 in our PD unit. Data of the patients included demographic characteristics, causes of primary renal disease, microbiology, and outcomes (resolution, catheter loss, and death) of peritonitis episodes. Results: During the study period, 143 PD-related peritonitis episodes were identified in 69 patients. The peritonitis rate was 0.56 episodes per patient-year. Overall, 62.9% of the episodes were due to Gram-positive organisms, 32.1% were due to Gram-negative organisms, 3.4% were culture negative and 1.3% were candida. Coagulase-negative staphylococci were isolated in half of the Gram-positive episodes. Acinetobacter and Pseudomonas were the most frequently observed microorganisms among Gram-negative episodes. Overall, 81.1% of cases improved completely with medical treatment. The PD catheter was removed in 27 (18.8%) patients, and two patients died from sepsis. Gram-negative organisms resulted in a significantly higher rate of catheter removals and a lower rate of resolution than Gram-positive organisms (p<0.001). Conclusion: Reducing the incidence of PD-related peritonitis could be possible by knowledge of prevalent microbial agents in each center, adjusting empirical treatment accordingly, and taking the necessary measures to prevent peritonitis attacks. [ABSTRACT FROM AUTHOR]

Objective: This study investigates correlations between different methods for diagnosis of protein energy malnutrition (PEM) in peritoneal dialysis patients. Methods: Twenty four patients were included. Patients with amputations, infections, peritonitis, malignancies and PD duration less than three months were excluded. Physical examination findings, laboratory results and anthropometric measurements were recorded. Body composition analysis was performed with multi-frequency bioimpedance analyzer. Dialysis malnutrition score (DMS) was calculated. The correlations of different parameters were searched. Results: Eleven patients were female and 13 patients were male. Mean age was 58.9±12.6 years. Median dialysis duration was 25 (interquartile range: 14) months. Protein percentage was negatively correlated with fat percentage (r=-0.785; p<0.001), triceps skinfold thickness (SFT) (r=-0.641; p<0.001), biceps SFT (r=-0.685; p<0.001), body mass index (BMI) (r=-0.867; p<0.001), mid-arm circumference (r=-0.680; p=0.001). Fat percentage was positively correlated with BMI (r=0.780; p<0.001), biceps SFT (r=0.817; p<0.001), triceps SFT (r=0.901; p<0.001) and mid-arm circumference (r=0.558; p=0.005) Albumin was negatively correlated with DMS (r= -0.439; p=0.032). DMS and albumin were not correlated with bioimpedance and anthropometry. Conclusion: Albumin is a marker of PEM in PD patients. Malnutrition scores may be used as adjunct methods. Increase in fat mass and percentage may influence the interpretation of anthropometric measurements. [ABSTRACT FROM AUTHOR]

Amaç: Türkiye'de 2018 yılı sonu itibarıyla periton diyalizinin (PD) tüm diyaliz popülasyonu içindeki oranı yıllar itibarıyla düşüş göstererek %3,94 olmuştur. Bu azalmanın nedenleri, yeni PD hastalarında düşüşün yanı sıra PD'den ayrılan hasta ve böbrek nakli sayılarındaki artıştır (prevalans %21,24). Bu çalışmada, 2010-2017 yılları arasında ünitemizde PD'den ayrılma nedenlerini araştırdık. Gereç ve Yöntemler: Çalışma PD hastalarının dosyaları gözden geçirilerek geriye dönük olarak gerçekleştirildi. Kısa PD süresi olan (

Öz: Amaç: Akut periton diyalizi (APD) yapılan yenidoğanların altta yatan nedenlerini ve sonuçlarını değerlendirmekGereç ve Yöntem: APD yapılan hastaların çoğunda akut böbrek yetmezliği (ABY) (n=21, %70) ve sepsis-dirençli metabolik asidoz (n=5, %16.7) vardı. ABY'nin diğer nedenleri renal agenezi (n=2, %9.5), perinatal asfiksi (n=4,%19), multikistik displastik böbrek (n=3, %13.3) ve konjenital kalp hastalığı (n=4, %19) idi. Ortalama diyaliz süresi 7.8±9.3 gün idi. En sık görülen komplikasyonlar kateter tıkanıklığı (n=8, %34.8) ve kateter girişinden sızıntı (n=5, %21.7) idi. Mortalite oranı % 70 idi; 8 hasta (%38) APD sürecinde altta yatan hastalıklar nedeniyle öldü. Hayatta kalan 9 hastanın izlemi sırasında 3 hasta (%33.3) tam remisyon gösterdi, ancak kalan 6 hastada kronik böbrek yetmezliği, altta yatan metabolik hastalıklarına yönelik klinik bulgular devam etti.Bulgular: APD yapılan hastaların çoğunda akut böbrek yetmezliği (ABY) (n=21, %70) ve sepsis-dirençli metabolik asidoz (n=5, %16.7) vardı. ABY'nin diğer nedenleri renal agenezi (n=2, %9.5), perinatal asfiksi (n=4,%19), multikistik displastik böbrek (n=3, %13.3) ve konjenital kalp hastalığı (n=4, %19) idi. Ortalama diyaliz süresi 7.8±9.3 gün idi. En sık görülen komplikasyonlar kateter tıkanıklığı (n=8, %34.8) ve kateter girişinden sızıntı (n=5, %21.7) idi. Mortalite oranı % 70 idi; 8 hasta (%38) APD sürecinde altta yatan hastalıklar nedeniyle öldü. Hayatta kalan 9 hastanın izlemi sırasında 3 hasta (%33.3) tam remisyon gösterdi, ancak kalan 6 hastada kronik böbrek yetmezliği, altta yatan metabolik hastalıklarına yönelik klinik bulgular devam etti.Tartışma: APD yenidoğan yoğun bakım ünitelerinde sıklıkla kullanılan tedavi şeklidir. Peritonit gibi hayatı tehdit eden komplikasyonları olsa da, bu tür komplikasyonlar nispeten daha az yaygındır. APD ihtiyacı için erken tanıma ve erken APD işleminin başlaması bu hastalarda mortalitenin azalmasına katkıda bulunabilir.

Amaç: Bu çalışmanın amacı hemodiyaliz (HD) ve periton diyalizi (PD) hastalarında yaşam kalitesini incelemektir. Ayrıca, yaşam kalitesi ile klinik ve demografik faktörler arasındaki ilişkiler incelenmiştir.Gereç ve Yöntem: Diyaliz tedavisi alan hastalar bu kesitsel çalışmaya dahil edildi. Demografik veriler, hastalık öyküsü, laboratuvar verileri toplandı. Komorbidite seviyesini puanlamak için Charlson komorbidite indeksi (CCl) kullanıldı. Sağlıkla ilişkili yaşam kalitesi (SYK), Böbrek Hastalığı İlişkili Yaşam Kalitesi Kısa Form Versiyon 1.3 (KDQOL-SF 1.3) ile ölçülmüştür.Bulgular: Çalışmaya 60'ı HD, 45'i PD tedavisi altında (% 45.7'si kadın; ort. yaş 54.63 ± 13.86) toplam 105 hasta alındı. PD hastaları beş alanda KDQOL-SF 1.3 alt ölçek puanları (duygusal rol, iş durumu, bilişsel işlev, diyaliz personelinin teşviki, hasta memnuniyeti) HD hastalarına göre daha yüksek puanlara sahipti. İleri yaş, kadın cinsiyet, düşük eğitim düzeyi, yüksek komorbidite skoru ve son 12 aydaki hastanede yatış sürelerinin yaşam kalitesi ile ilişkili olduğu bulundu. Bazı KDQOL-SF 1.3 alt ölçekleri ile hemoglobin, albümin arasında pozitif; ferritin düzeyleri arasında negatif korelasyonlar olduğu tespit edildi.Sonuç: Çalışmamıza göre, SYK, PD hastalarında HD hastalarına göre, KDQOL-SF 1.3'ün spesifik alanlarında daha iyiydi. Yaş, cinsiyet, eğitim düzeyi, hemoglobin, albümin ve ferritin düzeyleri SYK ile ilişkiliydi.

Objective: This study aims to investigate the relationship between peritonitis attacks and mannosebinding lectin (MBL) gene polymorphism in patients undergoing peritoneal dialysis. Method: Codon 54 polymorphism found in exon 1 of the MBL gene was investigated by polymerase chain reaction-restriction fragment length polymorphism method in 45 patients with chronic renal failure undergoing peritoneal dialysis. Results: The frequency of the mutant B allele was not significantly higher in the patient group (4.4%) than the control group (2.1%). The AB genotype was found at a rate of 15.6% and 34% in the patient group and healthy control group, respectively. The AA genotype was found in 80% of children who underwent peritoneal dialysis and 63.8% of the healthy control group. Conclusion: In our study, no relationship was found between peritonitis attacks and MBL gene polymorphism in patients undergoing peritoneal dialysis. [ABSTRACT FROM AUTHOR]

Objective: Cardiovascular morbidity seems increased in children with chronic renal failure, but the age and stage of disease when cardiac alterations become manifest are unknown. The aim of our study was aimed to evaluate the left ventricular geometry of children with chronic renal failure (CRF) undergoing peritoneal dialysis. Material and Methods: Echocardiographic and biochemical data were evaluated in 20 children on peritoneal dialysis (PD). Left ventricular mass index and relative wall thickness was calculated. There were 20 healthy control. Results: Left ventricular mass index and relative wall thickness were found significantly higher in CRF group compared to control group (respectively 88.03±37.09; 41.16±12.52 and 0.62±0.12; 0.39±0.08, p>0.05). There was significant correlation between left ventricular mass index and systolic blood pressures and parathormone (respectively r=0.428, p=0.03; r=-0.501, p=0.02). An abnormal left ventricular geometric pattern was present in 17/20 (85%) children with CRF. Concentric hypertrophy was the most common geometric pattern in the study. Nine (45%) of patients with CRF had left ventricular concentric hypertrophy. Left ventricular systolic functions were found normal in patients with CRF(EF 65.63±6.71% and FS 35.7±10.25%). Conclusion: Left ventricular hypertrophy (LVH) can be progresses in children with chronic renal failure. The strict control of blood pressure and hyperparathyroidism might be important in preventing the development of LVH in these patients. [ABSTRACT FROM AUTHOR]

Objectives: Fibromyalgia syndrome (FMS) is characterized by fatigue, memory problems, and widespread pain. The syndrome is present in about %2-8 of the general population. However, knowledge about this topic in specific populations is limited. Our aim was to evaluate FMS in patients undergoing peritoneal dialysis, hemodialysis, and control group, and the association between clinical and laboratory parameters.Patients and Methods: Eighty-nine dialysis patients and healthy volunteers were included in the study. The control group compromised 30 healthy adults (9 females 21 males with mean age of 52,9±16,3 years), 26 patients (7 females 19 males, with mean age of 53±15,9 years) receiving peritoneal dialysis and 33 patients (11 females and 22 males, with mean age of 64,5±7,1 years) receiving hemodialysis were enrolled in this study. Fibromyalgia was diagnosed with the criteria of 1990 American College of Rheumatology (ACR) and 2011 modification of the ACR preliminary diagnostic criteria. Gender, age, renal function tests, electrolytes, parathyroid hormone, renal failure etiology, and how long has it been dialyzed were recorded. Results: The prevalence of fibromyalgia was higher in patients with peritoneal dialysis compared with hemodialysis group. There was no statistically significant between peritoneal dialysis group and healthy group. Also, there was no statistically significant between for depression and cognitive functions between peritoneal dialysis group and healthy group. But, the parameter was found to be high in patients receiving hemodialysis compared with peritoneal and healthy groups. Kidney function tests and electrolyte levels were significantly different between healthy adults and dialysis groups (p lt;0.001).Conclusion: The prevalence of fibromyalgia was similar between peritoneal dialysis and healthy group. It may be related to actively participate in treatment, fewer stress factors, and better preservation of renal functions.

Copyright of Pamukkale Medical Journal is the property of Pamukkale Journal of Medicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Aim: To evaluate the effects of residual renal function (RRF) on anemia treatment, phosphorus control and nutritional parameters in peritoneal dialysis (PD) patients. Methods: PD patients were retrospectively analyzed. Besides anthropometric measurements, biochemical measurements, such as residual glomerular filtration rate (rGFR), normalized protein catabolic rate (nPCR), hemoglobin (Hb), serum albumin, calcium, phosphorus, ferritin, parathormone and C-reactive protein levels were recorded. Results: One hundred and fifteen patients (52 females, 63 males; mean age: 56.0±13.2 years 20-83 years) receiving PD treatment were analyzed. The patients were divided into two groups according to presence or absence of RRF (n=75 and n=40, respectively). Patients with RRF had higher body weight (80±14 kg vs 68±13 kg; p<0.001), body mass index (29±5 kg/ m² vs 25±5 kg/m²; p=0.009) and serum albumin level (3.6±0.5 vs 3.4±0.5 g/dL; p=0.027]. Patients with RRF had lower erythropoietin [29 (39%), vs. 34 (85%); p<0.001), sevelamer [17 (22.7%) vs 24 (60%); p<0.001] and calcimimetic [9 (12%) vs 14 (35%); p=0.007] usage rates and lower ferritin [159 (88-259) ng/mL vs 323 (170-495) ng/mL; p=0.001] level. rGFR was found to be positively correlated with Hb (r=0.274; p=0.017) and nPCR in patients with RRF (r=0.251; p=0.030). Conclusion: In our study, the positive effects of RRF on the treatment of anemia, phosphorus control and nutritional status in PD patients were shown. [ABSTRACT FROM AUTHOR]

Background: The prevalence of End-Stage Renal Disease (ESRD) has significantly increased in developing countries and similar to the worldwide trend, the number of incident Chronic Kidney Disease (CKD) stage 5 patients is also increasing in the Iran. This study aims to compare the Labor force participation in patients with hemodialysis and Peritoneal Dialysis (PD) treatment. Method: The cross sectional study was conducted on 208 patients referred to dialysis centers of north of Iran and Tehran, between January 2015 and January 2016. A checklist was designed to gather data of labor participation and socioeconomic status of patients. In addition Kidney Disease Quality of Life (KDQOL) questionnaire was used to calculate mental and physical health of patients. All statistical analysis were done using STATA SE software version 13.1. Results: The study highlights several findings including the higher mental and physical health quality of life, higher average monthly income in PD employed patients. Also, the type of treatment had significant relationship with labor force participation and it was higher for patients using peritoneal dialysis. Conclusion: It seems the government and especially ministry of health and medical education should give more attention to inform the public about the advantages of PD and especially its positive impact on employment of patients [ABSTRACT FROM AUTHOR]

Objective: Chronic kidney disease (CKD) is an inflammatory process. Serum proinflammatory cytokines are known to be ten times higher in patients with CKD when compared to normal population. Monocyte/High density lipoprotein (HDL) cholesterol ratio (MHR) have been shown to be a new marker of inflammation and claimed that, it may be used to predict cardiovascular events in patients with CKD. This cross-sectional study aimed to compare monocyte / HDL cholesterol ratio in patients treated with hemodialysis and peritoneal dialysis. Methods: Files of patients who have been followed up with end stage renal disease (ESRD) and have peritoneal dialysis or hemodialysis therapy in Nephrology Clinic of our hospital have been retrospectively examined. Patients were divided into two groups regarding renal replacement treatment type. Monocyte / HDL cholesterol ratio was compared between groups. IBM SPSS Statistics 22.0 (IBM Corp., NY, USA) packaged software and appropriate statistical methods were used to analyse data. Results: Monocyte / HDL cholesterol ratio was significantly higher in patients treated with hemodialysis (p= 0.028). HDL cholesterol levels were significantly higher in peritoneal dialysis group (p= 0.046). Total cholesterol, LDL cholesterol, triglyceride and VLDL cholesterol have been ascertained to be similar in both patient groups (p> 0.05). The high sensitivity CRP and sedimentation levels have been detected to be similar within the groups (p> 0.05). Conclusion: This is the first study evaluating the monocyte/HDL cholesterol ratio among renal replacement therapy modalities in our literature review. In this study, it has been shown that; monocyte/HDL cholesterol ratio were statistically higher in patients having hemodialysis than in the ones followed up with peritoneal dialysis. According to these results, it may be considered that; peritoneal dialysis may be associated with less systemic inflammation than hemodialysis. [ABSTRACT FROM AUTHOR]

Copyright of Turkiye Klinikleri Journal of Internal Medicine / Türkiye Klinikleri İç Hastalıkları Dergisi is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Purpose: This study aimed to examine the quality of life (QOL) in hemodialysis (HD) and peritoneal dialysis (PD) patients. Additionally, associations between QOL and clinical and demographic factors were investigated. Materials and Methods: Patients under dialysis treatment were included in this cross-sectional study. Demographic data, disease history, and laboratory data were collected. Charlson comorbidity index (CCl) was used to score the level of comorbidity. Health-related quality of life (HRQOL) was measured by Kidney Disease Quality of Life Short Form Version 1.3 (KDQOL-SF 1.3). Results: One hundred and five patients, 60 of whom were under HD, and 45 were under PD (45.7% were females; mean age 54.63±13.86 years) were enrolled in the study. PD patients had better scores in five domains of the KDQOL-SF 1.3 questionnaire (emotional role, work status, cognitive function, dialysis staff encouragement, patient satisfaction). Older age, female sex, lower education level, high comorbidity score and, hospitalization in the last 12 months were found to be related to low QOL. We detected positive correlations between serum hemoglobin levels, albumin, and some subgroups of KDQOL-SF 1.3 scale; whereas negative correlations were detected between serum ferritin levels and some of the KDQOL-SF 1.3 items. Conclusion: According to our study, HRQOL was better in PD patients compared to HD in specific domains of the KDQOL-SF 1.3. Age, gender, education level, hemoglobin level, albumin, and ferritin were associated with HRQOL. [ABSTRACT FROM AUTHOR]

Introduction: Erythropoietin (Epo) is a hormone that is synthesized in the kidneys and that stimulates the erythropoiesis in the bone marrow. Epo has effects apart from the erythropoiesis. In chronic renal failure (CRF) patients, hemorrhagic diathesis is observed, and Epo production is decreased. Erythropoiesis-stimulating agents (ESAs) are widely used in the treatment of renal anemia in these patients. Our study aimed to investigate the effect of ESAs use on platelet aggregation in peritoneal dialysis (PD) patients due to CRF. Methods: Forty-three PD patients were included in the study. Seventeen patients had been using ESAs for anemia for at least three months (ESAs user group). Twenty-six patients were not using ESAs since they did not have indications (non- ESAs user group). Platelet aggregation measurement from the whole blood was carried out in each patient by a multiplate device. The calculated values [area under the curve (AUC), aggregation, and velocity] were recorded. The results were evaluated statistically, and p<0.05 was accepted as statistically significant. Results: In the non-ESAs user group, the mean hemoglobin level was found higher when compared to the other group, and this difference was statistically significant (p<0.001). The percentage of transferrin saturation was found higher in the ESAs user group (p=0.021). It was observed that AUC, aggregation, and velocity values were lower in the ESAs user group, and the result was not statistically significant (p values were 0.202, 0.329, 0.290, respectively). Conclusion: ESAs use in PD patients did not have any effect on platelet aggregation. Further prospective studies involving platelet aggregation tests before and after ESA treatment in dialysis patients are needed. [ABSTRACT FROM AUTHOR]

Şilöz asit; periton diyalizi yapılan hastalarda nadir görülen fakat önemli bir non-enfeksiyöz komplikasyondur. Konjenial nefrotik sendromlu 1,5 aylık erkek hasta genel durumunda kötüleşme, diffüz ödematöz görünüm ve solunum sıkıntısı nedeni ile çocuk yoğun bakım ünitesine kabul edildi. Yatışının üçüncü gününde periton diyaliz kateteri takılarak periton diyalizi uygulanmaya başlandı. Periton diyaliz kateteri takıldıktan beş gün sonra (yatışının sekizinci gününde) diyaliz sıvısı süt görünümü almaya başladı. Süt görünümündeki sıvının biyokimyasal analizi şilöz asit karakteri gösteriyordu: trigliserit 468 mg/dl. Şilöz asit kısa zincirli yağ asitlerinden zengin düşük lipidli diyet ve somatostatin analogu (octreotid) infüzyonu ile tedavinin 5. gününde düzeldi ve hasta tedavinin devamı için pediatri servisine transfer edildi.

Copyright of Turkiye Klinikleri Journal of Medical Ethics-Law & History / Türkiye klinikleri tıp Etiği, Hukuku ve Tarihi Dergisi is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Turkish Journal of Trauma & Emergency Surgery / Ulusal Travma ve Acil Cerrahi Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Online Turkish Journal of Health Sciences (OTJHS) / Online Türk Sağlık Bilimleri Dergisi is the property of Oguz KARABAY and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: Asymmetric dimethylarginine (ADMA) is known as a non-traditional risk factor for cardiovascular disease. Considering the increased prevalence of hypervolemia and heart failure in patients with peritoneal dialysis (PD), we aimed to investigate the relationship of ADMA with other biochemical parameters, echocardiographic findings, and results of bioimpedance analysis, which is a method for the determination of body fluid distribution in detail. Methods: The study was conducted on 21 patients with chronic PD. Bioimpedance was evaluated by Body Composition Monitor H02.201.1®. ADMA level was analyzed by an ELISA kit. Results: The mean ADMA level was 87.6±58.2 (18.54-247.34) μmol/L. The mean ADMA level in patients with hypertension was significantly higher than those with normal blood pressure (95.8±58.8 μmol/L and 41.0±27.9 μmol/L, respectively; p=0.045). In univariate analysis, the parameters associated with serum ADMA levels were uric acid (r=0.681, p=0.001), left ventricular end-systolic diameter (LVESD) (r=0.509, p=0.019), intracellular water (ICW) (r=0.606, p=0.004), extracellular water (r=0.471, p=0.031), dialysate-to-plasma (D/P) creatinine ratio (r=0.452, p=0.04), body surface area (r=0.52, p=0.016), total body water (r=0.581, p=0.006), and lean tissue mass (r=0.528, p=0.014). In multivariate analysis, only uric acid level, ICW, LVESD, and D/P creatinine were found to be significantly associated with ADMA. Conclusion: Serum ADMA level may be a useful marker to detect cardiovascular risk in patients with PD. Serum uric acid and LVESD are important parameters related to ADMA levels in patients with PD. Bioimpedance spectroscopy findings support the association of ADMA with body fluid volume. [ABSTRACT FROM AUTHOR]

OBJECTIVE: TFF3 is a small peptide hormone secreted from mucous producing cells and many epithelial cells. TFF3 inhibits apoptosis, promotes migration and facilitates restoration against injury. In our cross-sectional study, TFF3 levels in peritoneal fluids of peritoneal dialysis (PD) patients were measured and associated factors were investigated. MATERIAL and METHODS: Peritoneal fluid after a 12-hour dwell and concurrent serum samples of 48 chronic PD patients were collected. Serum and peritoneal fluid TFF3 levels were measured by ELISA. The SPSS15.0 package was used for statistical analysis of database files. RESULTS: The study included 48 patients (men/women; 24/24, mean age: 51.6±13.9 years) with a median PD vintage of 43 months (3-200). Median effluent TFF3 level was 17.07 ng/ml (2.38-99.4). There was no relationship between the number of peritonitis episodes and TFF3 levels. There was a positive correlation between effluent TFF3 levels and PD vintage (r=0.349, p<0.015). There was also a positive correlation between effluent TFF3 and serum PTH. Median serum TFF3 was 1.56 ng/ml (0.79- 11.05). There was no association between serum TFF3 levels and clinical features. After multivariate analysis, the only association was between effluent TFF3 and PD vintage. CONCLUSION: Effluent TFF3 levels increasing with dialysis vintage may be related to local production or peritoneal transport. [ABSTRACT FROM AUTHOR]

OBJECTIVE: The Turkish Society of Nephrology registry collects data on hemodialysis, peritoneal dialysis and transplantation on an annual basis. Registry reports are printed every year as a booklet and this is the 27th year of the registry reports. The registry is in close collaboration with international registries. MATERIAL and METHODS: In this paper, data from the 2016 registry report are summarized and yearly trends in the management of end-stage renal disease are also provided. RESULTS: The number of patients on renal replacement therapy is increasing. At the end of 2016, 74475 patients were on renal replacement therapy. The prevalence and incidence of end-stage renal disease was 933 and 140 per million population, respectively. Diabetes was the most important cause of end-stage renal disease. Hemodialysis (76.1%) was the most common type of treatment modality, followed by transplantation (19.2%) and peritoneal dialysis 4.7%). CONCLUSION: End-stage renal disease is a very important and growing health problem for our country. The renal registry of the Turkish Society of Nephrology is one of the leading tools for providing current and sound data on this public health problem. [ABSTRACT FROM AUTHOR]

OBJECTIVE: We studied the effect of initial peritoneal equilibration test (PET) results on mortality in peritoneal dialysis (PD) patients besides classical mortality markers. MATERIAL and METHODS: Seventy-eight patients were enrolled. Initial PET and biochemical and clinical findings were recorded after the beginning of PD. Survival analysis model included comorbidities, PD modality, peritoneal modality change during follow-up, history of peritonitis, calcium X phosphorus, dialysate volume, presence of anuria, ultrafiltration volume, albumin, Kt/V, normalized protein equivalent of nitrogen appearance (nPNA), and peritoneal permeability. RESULTS: The mean age was 55.2±13.8 (52.6%, female) years and PD duration was 49.7±26.1 months. When current conditions of the patients were evaluated, 42.3% of the 78 patients received PD treatment, 24.4% switched to hemodialysis, 6.4% had kidney transplantation and 26.9% died. The most significant factors determining patient survival were age, albumin and weekly total Kt/V according to the Cox regression analysis using the backward elimination method. When Cox regression analysis was repeated by the forward selection method, albumin was detected as the most significant factor determining patient survival. CONCLUSION: Albumin was found to be the most important factor predicting patient survival among peritoneal permeability, nPNA, PD modality, weekly total Kt/V, dialysate volume, ultrafiltration volume on the initial PET. [ABSTRACT FROM AUTHOR]

OBJECTIVE: In peritoneal dialysis (PD) patients, a low level of serum 25-hydroxyvitamin D is associated with an increased risk of cardiovascular events. Hyperuricemia is also associated with an increased mortality rate in chronic kidney disease patients. The aim of our study was to determine whether there was a relationship between serum uric acid and 25-hydroxyvitamin D in PD patients. MATERIAL and METHODS: A total of 48 PD patients were included in the study. Uric acid and 25-hydroxyvitamin D were determined simultaneously in each patient's serum. Mean serum uric acid and 25-hydroxyvitamin D levels of the patients were compared with each other. The cases where the P-value was below 0.05 were considered statistically significant. RESULTS: There was a statistically significant positive correlation between mean serum uric acid and 25-hydroxyvitamin D levels in PD patients (p=0.003; r=0.427). CONCLUSION: Serum uric acid and 25-hydroxyvitamin D levels in peritoneal dialysis patients may be indicative of dietary incompatibility. Prospective studies involving more patients are needed in PD patients to prove a relationship between these two serum markers. [ABSTRACT FROM AUTHOR]

OBJECTIVE: Apelin-13 is a biomarker that was shown to be related to cardiovascular disease risk in peritoneal dialysis patients. The aim of our study was to investigate the association of serum apelin-13 levels with inflammation, carotid artery intima media thickness (CIMT) and echocardiographic parameters in peritoneal dialysis patients. MATERIAL and METHODS: 33 patient receiving peritoneal dialysis treatment (15 female) and 27 healthy controls (11 female) were enrolled. CIMT and echocardiographic measurements of all patients and controls were taken. Serum apelin-13 levels were measured by ELISA. Apelin-13, c-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), echocardiographic parameters and CIMT values were compared between patients and controls. RESULTS: Apelin-13 was lower in the patient group [58 (12-131) ng/L] than in the control group [76 (18-130) ng/L] (p=0.083). CRP, NLR, CIMT were significantly higher in patients than controls (p<0.001). CIMT was 0.8 (0.4-1.5) mm and 0.60 (0.3-0.7) mm in the patients and the controls, respectively. Negative correlations were observed between Apelin-13 and age, ferritin, CRP, NLR and CIMT while positive correlations were found between calcium, ejection fraction (EF) and albumin. There was no correlation between apelin-13 and echocardiographic parameters except EF. CONCLUSION: Apelin-13 levels tend to be lower in peritoneal dialysis patients, and may be important in the development of inflammation, endothelial dysfunction, and atherosclerosis. [ABSTRACT FROM AUTHOR]

The prevalence of co-morbid gastrointestinal symptoms is high in dialysis patients, while abdominal pain, constipation, diarrhea, anorexia and abdominal bloating are the second-most common group of symptoms following dyspeptic symptoms. Underlying these symptoms is a wide spectrum of lower gastrointestinal disorders such as diverticular disease, angiodysplasia, mesenteric ischemia, ischemic colitis, colonic perforation, fecal impaction and stercoral ulcer, dialysis-related amyloidosis, encapsulating peritoneal sclerosis, and idiopathic dialysis ascites. Also, infarcts due to non-occlusive intestinal ischemia are less common but severe complications. Incidence of gastrointestinal disorders is considered to increase with the duration of renal failure, independent of dialysis modality. While uremia and dialysis have been linked to an increased risk of gastrointestinal tract lesions, pathogenesis of gastrointestinal dysfunction in end-stage renal disease is considered multifactorial and has not yet been clarified. In addition, conflicting data exist on the association of renal dysfunction with gastrointestinal disorders, and there are no explicit guidelines for the management of co-morbid gastrointestinal problems in patients with concomitant renal failure. Herein, we review the common lower gastrointestinal disorders that occur among dialysis patients, with an emphasis on prevalence, pathogenesis and diagnostic strategies. [ABSTRACT FROM AUTHOR]

Objective: Peritoneal dialysis (PD) is the most commonly used renal replacement therapy in acute and chronic renal insufficiency during neonatal and infantile periods, but many problems are encountered in practice. The aim of the study is to identify the problems seen in PD applications in this group of patients. Material and Methods: Between 2002 and 2013, files of 39 patients under 1 year of age who underwent acute or chronic PD in our department were retrospectively reviewed. Patients in the neonatal and infantile group were compared in terms of PD applications and their complications. Results: Acute PD was performed in a total of 27 patients (15 newborns, 12 infants). Mean duration of acute PD was not different in newborns and infants (9.2±10.5 vs II.6±13.7 days). Complication rale was not different in newborns (173.3%) and in infants (91.6%) (p=0.183). Non-infectious complications were more frequent in newborns and the most common complication was pericatheter leakage. The catheter was replaced in 46.6% of the newborns and in 8.3% of the infants due to non-infectious complications. Mortality rates were 66.7% (n=10) in newborns and 58.3% (n=7) in infants (p=0.706). Chronic PD was performed in a total 12 patients (8 newborns, 4 infants). Mean followup duration of chronic PD was 30.6+25.3 months in newborns, and 23.5±23.2 months in infants. Although overall complication rate was not different between two groups, non-infectious complications such as pericatheter leakage, and catheter obstruction were more frequent in newborns (212.5% vs 175%) (p=0.035). Although infectious complications were more common in infants (150% vs 112.5%), there was no statistical significant difference between both groups (p=0.646). Mortality rates were found to be 50% (n=4) in newborns and 50% (n=2) in infants. Conclusion: The most important complications of acute and chronic PD in the newborns were pericatheter leakage and catheter obstruction while peritonitis was the most common problem in chronic infantile PD. [ABSTRACT FROM AUTHOR]

Copyright of Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

OBJECTIVE: There is little knowledge on the differences between PD or HD initiation in terms of early and late morbidity and other complications. We aimed to compare the effect of different dialysis modalities on inflammation and other complications in a one-year prospective follow-up. MATERIAL and METHODS: The patients were divided into three groups depending on their dialysis requirements and compared in terms of inflammation and complications. Group 1: The patients who had acute dialysis indication and started urgent PD (n=23), Group 2: The patients who had acute dialysis indication and started urgent HD (n=21), Group 3: The patients with no acute dialysis indication and started dialysis two weeks after PD catheter insertion (n=20). RESULTS: HD patients had significantly lower urine levels and higher hemoglobin levels after 12 months in comparison with other groups. Complications of catheter-related infections were similar among the three groups, although catheter-related leaks were only found in the urgent PD group. There were no differences in terms of inflammatory markers among the groups. CONCLUSION: Urgent PD could be an alternative modality in end-stage renal disease patients with acute dialysis requirement. [ABSTRACT FROM AUTHOR]

Aim: Asymmetric dimethylarginine (ADMA) is associated with increased coronary artery disease risk through endothelial dysfunction in dialysis patients. We aimed to investigate the role of flow-mediated dilatation (FMD), a non-invasive indicator of endothelial function, and ADMA in mortality in peritoneal dialysis (PD) patients. Methods: PD patients aged 18-80 years; with dialysis duration of at least three months were included. FMD measurement and ADMA levels were recorded. Outcome of the patients on the third year were analyzed with binary logistic analyses. Results: The mean age of the 55 patients was 53±15 years and the mean follow-up duration was 36 months. Mean FMD and ADMA levels were 10.6±6.4% and 81.8±48.0 mol/L, respectively. Eighteen patients died during follow-up. Age, presence of diabetes mellitus and ischemic heart disease, ultrafiltration amount and serum albumin level were related with mortality while gender, weekly Kt/V and ADMA levels were not. There was no significant relationship between ADMA level and FMD (p=0.873). FMD was negatively correlated with systolic and diastolic blood pressures (p=0.001, p<0.001, respectively). Hypertension was found to be the most important single factor determining FMD (p=0.037). Conclusion: Estimating endothelial function by FMD or measuring serum ADMA levels may not be useful for predicting mortality in PD patients. [ABSTRACT FROM AUTHOR]

Cardiorenal syndrome (CRS) is a general term that can reflect different clinical conditions in which cardiac and renal dysfunctions coexist. The main pathogenetic mechanisms playing a role in heart failure (HF) and CRS are neurohumoral adaptation, right ventricular dilatation and dysfunction and systemic inflammation. Persistence of these factors cause focal and segmental glomerulosclerosis, and tubulointerstitial fibrosis in the renal parenchyma. Diuretics, beta blockers, reninangiotensin- aldosterone system inhibitors, and vasodilators are the main medical treatments besides conventional approach, such as salt and water restriction and quitting smoking, in HF treatment. Diuretic resistance is the main problem emerging during diuretic treatments. Two renal replacement treatments have become prominent for removal of excess fluids via ultrafiltration in HF patients with diuretic resistance extracorporeal ultrafiltration with hemodialysis and peritoneal dialysis (PD). Herein, the role of these two ultrafiltration modalities, especially peritoneal ultrafiltration (PUF) in the treatment of HF is discussed. The main studies and advantages of PUF in HF treatment were discussed. Moreover, effects of PD on glomerular filtration rate, hospitalization and mortality were investigated. In conclusion, PD is an alternative cheap, practical and convenient therapy in reducing cardiac volume burden in HF patients who do not respond well to standard treatments and/or require frequent hospitalization. [ABSTRACT FROM AUTHOR]